Sort
64,565 grants matching “drug discovery”
Discovery and Analysis of Synthetic TLR Agonists and Antagonists
$651,422Dale L Boger · Scripps Research Institute, The · U24 · FY2011 · AI
Small Molecule Discovery for Particulate Guanylyl Cyclase Receptor B Enhancers
$651,411Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2019 · AG
The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention
$651,408Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression
$651,408Nancy H. Colburn · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
CF Corrector Ligands Discovered on CF Human Airway Cells
$651,403Erik Mills Schwiebert · Discoverybiomed, Inc. · R44 · FY2012 · DK
Clinical Pharmacology, Drug Action and Pharmacogenetics
$651,359Radojka Savic · University Of California, San Francisco · T32 · FY2023 · GM
Discovery Proteomics Core
$651,269Tukiet T Lam · Yale University · P30 · FY2024 · DA
Discovery Proteomics Core
$651,268Tukiet T Lam · Yale University · P30 · FY2022 · DA
Discovery Proteomics Core
$651,268Tukiet T Lam · Yale University · P30 · FY2021 · DA
High-Throughput Screening for Dab2 Inhibitors as Stabilizers of CFTR
$651,265Dean R Madden · Dartmouth College · R01 · FY2017 · DK
Development of screens for drugs in alcohol dependence
$651,253John M Littleton · University Of Kentucky · R01 · FY2007 · AA
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
$651,215William C Hahn · Broad Institute, Inc. · R01 · FY2023 · CA
Development of neutral sphingomyelinase 2 (nSMase2) inhibitors for the treatment of Alzheimer's disease
$651,180Takashi Tsukamoto · Johns Hopkins University · R01 · FY2023 · AG
Biomedical Data Translator Technical Feasibility Assessment and Architecture Design
$651,119Paul Andrew Clemons · Broad Institute, Inc. · OT3 · FY2017 · TR
Mechanism Based Inhibition of M Tuberculosis Enzymes
$651,113John S Blanchard · Albert Einstein College Of Medicine · R01 · FY2008 · AI
STRUCTURE, MECHANISM AND INHIBITION OF HIV PROTEINS
$651,019Harvard University · P01 · FY2001 · GM
Structure and function of PTH class B GPCR
$650,986Jean-Pierre Vilardaga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Validation of targets for therapeutic intervention in NASH
$650,969Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2018 · DK
Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics
$650,841Sanjiv J Shah · Northwestern University At Chicago · R01 · FY2019 · HL
Cartilage-Bone-Synovium MPS: Musculoskeletal Disease Biology in Space
$650,808Alan J Grodzinsky · Massachusetts Institute Of Technology · UG3 · FY2017 · TR
Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
$650,769Raymond F. Schinazi · Emory University · R01 · FY2022 · AI
Epigenetic Marks of Cocaine Addiction
$650,708Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2011 · DA
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
$650,707Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2023 · DK
Integrative genomic, transcriptomic and proteomic studies of pulmonary function and COPD
$650,695Ani Wang Manichaikul · University Of Virginia · R01 · FY2023 · HL
Genetics & Clinical Cohorts
$650,631Sarah Jane Dunstan · University Of Washington · U19 · FY2024 · AI